series-c-plus
Stage
4
Investors
About
Nkarta is a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat cancer.
Explore Nkarta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.